Analysis of electropharmacological and proarrhythmic effects of donepezil using the halothane-anesthetized intact dogs and the conscious chronic atrioventricular block ones.


Journal

Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264

Informations de publication

Date de publication:
04 2021
Historique:
received: 18 09 2020
accepted: 08 10 2020
pubmed: 17 10 2020
medline: 6 11 2021
entrez: 16 10 2020
Statut: ppublish

Résumé

Donepezil, an inhibitor for acetylcholinesterase used for patients with Alzheimer's disease, has been shown to inhibit I

Identifiants

pubmed: 33064166
doi: 10.1007/s00210-020-01997-w
pii: 10.1007/s00210-020-01997-w
doi:

Substances chimiques

Anesthetics, Inhalation 0
Cholinesterase Inhibitors 0
Donepezil 8SSC91326P
Halothane UQT9G45D1P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-589

Subventions

Organisme : Japan Society for the Promotion of Science (JSPS KAKENHI)
ID : 19K16505
Organisme : Japan Society for the Promotion of Science (JSPS KAKENHI)
ID : 20K16136
Organisme : Project Research Grant of Toho University School of Medicine
ID : 17-11
Organisme : Project Research Grant of Toho University School of Medicine
ID : 19-07

Commentaires et corrections

Type : CommentIn

Références

Chae YJ, Lee HJ, Jeon JH, Kim IB, Choi JS, Sung KW, Hahn SI (2015) Effects of donepezil on hERG potassium channels. Brain Res 1597:77–85
doi: 10.1016/j.brainres.2014.11.057
Farlow M, Veloso F, Moline M, Yardley J, Brand-Schieber E, Bibbiani F, Zou H, Hsu T, Satlin A (2011) Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease. BMC Neurol 11:57
doi: 10.1186/1471-2377-11-57
Fridericia LS (1920) Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken (in German). Acta Med Scand 53:469–486
doi: 10.1111/j.0954-6820.1920.tb18266.x
Harvey RD, Grant AO (2018) Agents used in cardiac arrhythmias. In: Katzung BG (ed) Basic & clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 228–253
Johannesen L, Vicente J, Mason JW, Sanabria C, Waite-Labott K, Hong M, Guo P, Lin J, Sørensen JS, Galeotti L, Florian J, Ugander M, Stockbridge N, Strauss DG (2014) Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil. Clin Pharmacol Ther 96:549–558
doi: 10.1038/clpt.2014.155
Katzung BG (2018) Special aspects of geriatric pharmacology. In: Katzung BG (ed) Basic & clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 1058–1067
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577–1579
doi: 10.1111/j.1476-5381.2010.00872.x
Kitt J, Irons R, Al-Obaidi M, Missouris C (2015) A case of donepezil-related torsades de pointes. BMJ Case Rep. https://casereports.bmj.com/content/2015/bcr-2015-211900
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (1999a) Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats. Eur J Pharmacol 380:101–107
doi: 10.1016/S0014-2999(99)00545-2
Kosasa T, Kuriya Y, Yamanishi Y (1999b) Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats. Jpn J Pharmacol 81:216–222
doi: 10.1016/S0021-5198(19)30790-5
Matsui K, Mishima M, Nagai Y, Yuzuriha T, Yoshimura T (1999) Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to rat. Drug Metab Dispos 27:1406–1414
pubmed: 10570021
McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160:1573–1576
doi: 10.1111/j.1476-5381.2010.00873.x
McLaren AT, Allen J, Murray A, Ballard CG, Kenny RA (2003) Cardiovascular effects of donepezil in patients with dementia. Dement Geriatr Cogn Disord 15:183–188
doi: 10.1159/000068781
Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS (2001) Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 37:278–285
doi: 10.1016/S0735-1097(00)01056-1
Pappano AJ (2018) Cholinoceptor-activating & cholinesterase-inhibiting drug. In: Katzung BG (ed) Basic & clinical pharmacology, 14th edn. McGraw-Hill Education, New York, pp 107–123
Satoh T, Zipes DP (1996) Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation 94:217–227
doi: 10.1161/01.CIR.94.2.217
Sugiyama A (2008) Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol 154:1528–1537
doi: 10.1038/bjp.2008.240
Sugiyama A, Hashimoto K (1998) Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring. Toxicol Appl Pharmacol 152:261–269
doi: 10.1006/taap.1998.8494
Sugiyama A, Ishida Y, Satoh Y, Aoki S, Hori M, Akie Y, Kobayashi Y, Hashimoto K (2002a) Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. Jpn J Pharmacol 88:341–350
doi: 10.1254/jjp.88.341
Sugiyama A, Satoh Y, Ishida Y, Yoneyama M, Yoshida H, Hashimoto K (2002b) Pharmacological and electrophysiological characterization of junctional rhythm during radiofrequency catheter ablation of the atrioventricular node: possible involvement of neurotransmitters from autonomic nervous system. Circ J 66:696–701
doi: 10.1253/circj.66.696
Takahara A, Sugiyama A, Ishida Y, Satoh Y, Wang K, Nakamura Y, Hashimoto K (2006) Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H
doi: 10.1038/sj.bjp.0706493
Takaya T, Okamoto M, Yodai K, Hata K, Kijima Y, Nakajima H, Nishikawa Y, Kita T, Ito M, Seo T, Kawashima S (2009) Torsades de pointes with QT prolongation related to donepezil use. J Cardiol 54:507–511
doi: 10.1016/j.jjcc.2009.03.011
Umegaki H, Khookhor O (2013) The response of the autonomic nervous system to the cholinesterase inhibitor, donepezil. Neuroendocrinol Lett 34:383–387
pubmed: 23922048
Van de Water A, Verheyen J, Xhonneux R, Reneman RS (1989) An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22:207–217
doi: 10.1016/0160-5402(89)90015-6

Auteurs

Mihoko Hagiwara-Nagasawa (M)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Ryuichi Kambayashi (R)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Ai Goto (A)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Yoshio Nunoi (Y)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Hiroko Izumi-Nakaseko (H)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Koki Chiba (K)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Takeshi Wada (T)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Yoshinori Takei (Y)

Department of Translational Research & Cellular Therapeutics, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Akio Matsumoto (A)

Department of Aging Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.

Atsushi Sugiyama (A)

Department of Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan. atsushi.sugiyama@med.toho-u.ac.jp.
Department of Translational Research & Cellular Therapeutics, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan. atsushi.sugiyama@med.toho-u.ac.jp.
Department of Aging Pharmacology, Faculty of Medicine, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan. atsushi.sugiyama@med.toho-u.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH